These findings are critical, as diabetes development is associated with oxidative stress38, and in vivo administration of the ROS scavenger TEMPOL in STZ-treated rats had a renoprotective effect and ameliorated the pathological changes in glomeruli, possibly by reducing the expression of TRPC6 channels39. The gene discussed is TRPC6; the disease is diabetes mellitus.